Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jihane Bouziane

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 2024
Practice-changing trials on breast cancerYoulia Kirova, Jihane Bouziane, Pierre Loap
International Journal of Cancer|May 23, 2025
Long-term cardiac outcomes in breast cancer patients treated with helical tomotherapy: Evaluating the applicability of 3D-based dose constraints for intensity modulated radiation therapyPierre Loap, Abdelkarim Uakkas, Jihane Bouziane, et al.
American Journal of Clinical Oncology|July 4, 2024
Concurrent Use of Radiotherapy and Ribociclib: Preliminary Results and Review of the LiteratureJihane Bouziane, Pierre Loap, Paul Cottu, et al.
Cancers|February 13, 2025
Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final AnalysisPierre Loap, Abdelkarim Uakkas, Sofiane Allali, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 25, 2024
Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approachJihane Bouziane, Pierre Loap, Kim Cao, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 18, 2025
Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: Excellent early tolerance or delayed skin reactions? Real life experienceJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
American Journal of Clinical Oncology|July 16, 2025
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the EfficacyJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
The British Journal of Radiology|July 12, 2025
Hypofractionated whole-breast radiation therapy with simultaneous integrated boost after breast-conserving surgery: preliminary real-life experience of the Radiation Therapy Oncology Group 1005 trialGokoulakrichenane Loganadane, Pierre Loap, Sofiane Allali, et al.
American Journal of Clinical Oncology|July 16, 2024
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the LiteratureJihane Bouziane, Pierre Loap, Kim Cao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 2024
Practice-changing trials on breast cancerYoulia Kirova, Jihane Bouziane, Pierre Loap
International Journal of Cancer|May 23, 2025
Long-term cardiac outcomes in breast cancer patients treated with helical tomotherapy: Evaluating the applicability of 3D-based dose constraints for intensity modulated radiation therapyPierre Loap, Abdelkarim Uakkas, Jihane Bouziane, et al.
American Journal of Clinical Oncology|July 4, 2024
Concurrent Use of Radiotherapy and Ribociclib: Preliminary Results and Review of the LiteratureJihane Bouziane, Pierre Loap, Paul Cottu, et al.
Cancers|February 13, 2025
Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final AnalysisPierre Loap, Abdelkarim Uakkas, Sofiane Allali, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 25, 2024
Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approachJihane Bouziane, Pierre Loap, Kim Cao, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 18, 2025
Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: Excellent early tolerance or delayed skin reactions? Real life experienceJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
American Journal of Clinical Oncology|July 16, 2025
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the EfficacyJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
The British Journal of Radiology|July 12, 2025
Hypofractionated whole-breast radiation therapy with simultaneous integrated boost after breast-conserving surgery: preliminary real-life experience of the Radiation Therapy Oncology Group 1005 trialGokoulakrichenane Loganadane, Pierre Loap, Sofiane Allali, et al.
American Journal of Clinical Oncology|July 16, 2024
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the LiteratureJihane Bouziane, Pierre Loap, Kim Cao, et al.
Pageof 1